COVID-19 incidence, hospitalization up for persons with disabilities
Jun 16, 2022
Medicare beneficiaries who are eligible because of disability have a higher COVID-19 incidence and hospitalization rates than age-eligible beneficiaries.
COVID-19 vaccines cut mortality with heart failure
Jun 16, 2022
Those who are partially vaccinated and unvaccinated face the same increased risk, whereas boosted and fully vaccinated adults fare best.
Risk for psychiatric illness up in early postacute COVID-19 phase
Jun 14, 2022
Risks for new-onset psychiatric diagnoses and anxiety disorders, but not mood disorders, increased in the early postacute phase.
Vaccine effectiveness against SARS-CoV-2 infection wanes over time
Jun 14, 2022
However, for all ages, vaccine effectiveness against severe COVID-19 was high overall, at 90% five months or longer after two doses.
Text messaging intervention does not improve COVID-19 vaccine uptake
Jun 13, 2022
No increase in vaccine uptake was seen for individuals receiving text message versus phone calls or for behaviorally informed message content.
Vaccination offers partial protection for postacute phase of COVID-19
May 31, 2022
Individuals with breakthrough infection have an increased risk for death and postacute sequelae compared with contemporary controls.
Multisystem abnormalities persist after COVID-19 hospitalization
May 31, 2022
Persisting evidence of cardio-renal involvement and hemostasis pathway activation was reported at 28 to 60 days after discharge.
Post-COVID conditions are common among adult survivors
May 25, 2022
There was a more than twofold risk of acute pulmonary embolism and respiratory signs and symptoms among survivors aged 18 to 64 and ≥65 years.
Persistent viral shedding common in hospitalized COVID-19 patients
May 13, 2022
Persistent viral shedding is associated with in-hospital delirium and increased six-month mortality.
Health Improves over two years for COVID-19 hospitalization survivors
May 12, 2022
Improvements were seen in physical and mental health, but survivors still have more symptoms than controls at two years.